Pfizer’s new weight-loss shot: Can one injection a month change obesity treatment as we know it?

With promising mid-stage trial results, berobenatide aims to make obesity treatment more convenient without compromising ...

One Injection A Month For Weight Loss? Pfizer's New Obesity Drug Explained

The natural GLP-1 hormone survives in the body for only a few minutes before it is broken down. Drug developers overcome this ...

Pfizer's once-a-month weight loss shot shows early promise, but years from approval

Pfizer's GLP-1 drug showed 12% weight loss over six months with just one monthly injection. Experts say it could be years ...

Pfizer berobenatide side effects compare to Wegovy in Phase 2b trial

Nausea and vomiting rates for the monthly injectable berobenatide came in close to benchmarks set by Novo Nordisk's weekly ...

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

By Michael Erman NEW YORK, June 6 (Reuters) - Pfizer presented data on Saturday that showed a monthly dose of an experimental ...

What to know about berobenatide, Pfizer’s experimental obesity drug

Pfizer's experimental drug, berobenatide, is designed to stay attached longer to a blood protein called albumin, helping prevent it from breaking down too quickly.
CNBC

Pfizer oral weight loss drug may be as effective as Ozempic injection by Novo Nordisk, study says

An oral drug from Pfizer causes a similar amount of weight loss as the blockbuster Ozempic injection, made by rival Novo Nordisk, according to results from a phase two clinical trial. The results were ...